rood blauwe elepsis logo Belegger.nl

NEL ASA 2020

2.883 Posts
Pagina: «« 1 ... 50 51 52 53 54 ... 145 »» | Laatste | Omlaag ↓
  1. [verwijderd] 26 augustus 2020 07:14
    quote:

    schreef:

    Nel ASA: Second quarter 2020 financial results

    (Oslo, 26 August 2020) Nel ASA (Nel) reported revenues of NOK 148.6 million in the second quarter of 2020, up from NOK 122.5 million in the same quarter of 2019 and an adjusted EBITDA of negative NOK 22.3 million. The order backlog grew
    75% to over NOK one billion and the company holds more than NOK 2.5 billion in cash. Nel reiterates the long-term outlook.

    "We are relatively happy with the second quarter revenue growth and an all-time high order intake, despite the Covid-19 situation. The markets in which we operate continue to show high activity and growth momentum, in addition to good governmental interest for developing green energy infrastructure and industries post Covid-19. It seems like renewable hydrogen will play a vital role in The Green Deal that should contribute to Europe becoming the first carbon neutral continent in the world, and Nel aims to leverage on these opportunities going forward," says Jon André Løkke, Chief Executive Officer of Nel.

    Nel reported revenues in the second quarter of 2020 of NOK 148.6 million (122.5), up 21% from the corresponding quarter in 2019 and the adjusted EBITDA ended at NOK -22.3 million, adjusted for non-recurring and other ramp-up costs. The reported EBIT was NOK -72.0 million (-90.7), while the pre-tax income ended at NOK 594.3 million (-94.7) following the listing of Nikola Corporation (Nikola) and the corresponding positive fair value adjustment of Nel´s shareholding in Nikola. The backlog grew 75% to approximately NOK one billion.

    During the second quarter of 2020, Nel completed a successful subsequent offering of gross NOK 127 million and completed a successful private placement raising NOK 1.3 billion, bringing the cash position to exceed NOK 2.5 billion.

    "Nel targets to have a strong financing to execute on our strategic plans. The private placement and subsequent offering were both oversubscribed, showing a
    solid backing from our shareholders. We want to maintain and strengthen our
    leading position in a growing market through accelerated investments in
    technology and organization, and experience an increased importance of being a
    financially strong counterpart, especially for larger contracts," Løkke comments.

    Nel remains committed to the growth strategy, including the electrolyser
    manufacturing scale-up project at Herøya, Norway, where pre-engineering studies
    have revealed a potential for the nameplate capacity per production line to be
    around 500 MW/year compared to previous target at 360 MW/year, enabling a total
    potential of around 2 GW/year at the facility. Nel has also taken on additional
    employees and costs to prepare for future growth during the quarter and holds
    the workforce largely intact to maintain the momentum when the Covid-19
    situation normalizes.

    "The pandemic will most likely continue to negatively impact the general
    business environment for the rest of this year, but the Covid-19 situation also
    accelerates the adoption of green hydrogen and industrial hydrogen applications
    across Europe, and we are now preparing for that, both in terms of manufacturing
    capacity and organisation. We remain confident in the long-term potential for
    the industry and reiterate the strong outlook," Løkke concludes.

    EBITDA and other alternative performance measures (APMs) are defined and
    reconciled to the IFRS financial statements as a part of the APM section of the
    second quarter and half year 2020 report on page 22, as well as in the
    accompanying presentation page 6.
  2. [verwijderd] 26 augustus 2020 09:01
    Een goede plus in omzet over Q2 met stabiele kostenuitgaven, tov Q1 en Q2 2019. Zeker met recente de order intake van €60mio en een uitbreiding van de cash positie van €250mio, inderdaad een mooie zoals verwacht.
  3. RW1963 26 augustus 2020 12:36
    Onze NEL vliegt de laatste tijd alle kanten op. De ene dag onder de NOK20, de andere dag weer boven de NOK21.
    Super riskant, maar voor daghandelaren misschien interessant.
    Als we per saldo maar beetje bij beetje blijven stijgen hoor je mij niet klagen :-)

    Andere aandelen die ik heb in deze sector mogen ook wel iets meer stijgen.
  4. RW1963 26 augustus 2020 12:37
    quote:

    Eric61 schreef op 26 augustus 2020 12:35:

    Nel, You are so beautiful. ( Joe Cocker )
    Jij hebt een grote platencollectie. Maar wel een goede smaak ;-)
  5. Eric61 26 augustus 2020 12:42
    U toch ook. Wonderful tonight. (Slowhand). Alles ziet er goed uit voor de belegger dus hopelijk rustig aan omhoog.
  6. [verwijderd] 26 augustus 2020 13:10
    quote:

    wist ik het maar schreef op 25 augustus 2020 17:04:

    vreemd dat er veel af is vlak voor cijfers morgen
    Bange beleggers, die vlak voor de cijfers weglopen hé. Die hebben daar vandaag alvast spijt van denk ik. Vertrouwen moeten we hebben, en gezien de kwartaalcijfers deze morgen is dit vertrouwen meer dan verdiend. You ain't seen nothing yet met Nel.
  7. Jackpot1983 26 augustus 2020 13:15
    Nel zit volgens mij overal goed tussen. Ik heb nu nog een paar duizend stuks en al een hele mooie winst gemaakt. Ik haal er nu ook niks meer uit. Ik wil weleens zien waar we over 5 jaar staan. Ik denk dat we straks harder gaan dan velen verwachten.
  8. RW1963 26 augustus 2020 13:42
    quote:

    Eric61 schreef op 26 augustus 2020 12:43:

    Wie is Slowhand ook alweer?
    Dat weet je wel. Maar ik zal je op weg helpen. Jij bent nl. naar hem genoemd. Eric Clapton ;-)
2.883 Posts
Pagina: «« 1 ... 50 51 52 53 54 ... 145 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.101
AB InBev 2 5.529
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.890
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.795
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.772
Aedifica 3 925
Aegon 3.258 322.988
AFC Ajax 538 7.088
Affimed NV 2 6.300
ageas 5.844 109.897
Agfa-Gevaert 14 2.061
Ahold 3.538 74.343
Air France - KLM 1.025 35.241
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.046
Alfen 16 25.074
Allfunds Group 4 1.511
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 409
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.580
AMG 971 134.070
AMS 3 73
Amsterdam Commodities 305 6.740
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.029
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.789
Arcelor Mittal 2.034 320.880
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.342
Aroundtown SA 1 221
Arrowhead Research 5 9.749
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.560
ASML 1.766 109.399
ASR Nederland 21 4.505
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.728
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.412